1. Ionic release from bioactive SiO 2 -CaO CME /poly(tetrahydrofuran)/poly(caprolactone) hybrids drives human-bone marrow stromal cell osteogenic differentiation.
- Author
-
Sory DR, Heyraud ACM, Jones JR, and Rankin SM
- Subjects
- Humans, Silicon Dioxide chemistry, Silicon Dioxide pharmacology, Biocompatible Materials pharmacology, Biocompatible Materials chemistry, Bone Regeneration drug effects, Cells, Cultured, Ions, Osteogenesis drug effects, Cell Differentiation drug effects, Mesenchymal Stem Cells drug effects, Mesenchymal Stem Cells metabolism, Mesenchymal Stem Cells cytology, Polyesters chemistry, Polyesters pharmacology
- Abstract
This study demonstrates that dissolution products of inorganic/organic SiO
2 -CaOCME /PTHF/PCL-diCOOH hybrid (70S30CCME -CL) drive human bone marrow stromal cells (h-BMSCs) down an osteogenic pathway with the production of mineralised matrix. We investigated osteogenesis through combined analyses of mRNA dynamics for key markers and targeted staining of mineralised matrix. We demonstrate that h-BMSCs undergo accelerated differentiation in vitro in response to the 70S30CCME -CL ionic milieu, as compared to incubation with osteogenic media. Extracts from 70S30CCME -CL promote osteogenesis by inducing changes in cellular metabolic activity, promoting changes in cell morphology consistent with the osteogenic lineage, and by enhancing mineralisation of hydroxyapatite in the extracellular matrix. Additionally, our results show that 70S30CCME -CL hybrids prove sustained functional resilience by maintaining osteostimulatory effects despite cumulated dissolution cycles. In co-differentiation medium, 70S30CCME -CL ionic release can modulate signalling pathways associated with non-osteogenic functions, further supporting their potential for bone regeneration applications. Overall, our study provides compelling experimental evidence that the 70S30CCME -CL hybrid is a promising biomaterial for bone tissue regeneration applications., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this study. All data presented in the manuscript was collected by the authors and the authors take complete responsibility for the integrity of the data and the accuracy of the data analyses., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)- Published
- 2025
- Full Text
- View/download PDF